mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer

Objective: Drug resistance remains a major challenge for effective breast cancer chemotherapy. Resveratrol (Res) is a promising candidate for overcoming cancer chemoresistance, but it has low bioavailability due to poor absorption, and ready metabolism limits its application. This study aims to develop a Res-loaded mixed micelle system to be effective on drug resistance of breast cancer cells. Methods: A mixed micelle system made of methoxy poly (ethylene glycol)-b-polycaprolactone (mPEG-PCL) and d-α-Tocopherol polyethylene glycol succinate was prepared and Res was encapsulated to form Res-loaded mixed micelles. Furthermore, the antitumor activity against doxorubicin (Dox)-resistant breast cancer MCF-7/ADR cells was studied and the possible mechanism was elucidated. Results: The mixed micellar formulation increased drug uptake efficiency of Res by Dox-resistant breast cancer MCF-7/ADR cells, and induced higher rates of apoptotic cell death, as assessed by the accumulation of Sub G1 phases of cell cycle, nucleus staining and Annexin-FITC/propidium iodide assay. Moreover, Res-loaded mixed micelles also markedly enhanced Dox-induced cytotoxicity in MCF-7/ADR cells and increased the cellular accumulation of Dox by downregulating the expression of P-glycoprotein (P-gp) and inhibiting the activity thereof. Conclusion: The cumulative evidence indicates that Res-loaded mixed micelles hold significant promise for the treatment of drug-resistant breast cancer.

[1]  P. Papageorgis,et al.  D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells. , 2014, Biochemical pharmacology.

[2]  Zhiwei Wang,et al.  Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. , 2010, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[3]  Hsiu-Chen Huang,et al.  Co-treatment with quercetin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose causes cell cycle arrest and apoptosis in human breast cancer MDA-MB-231 and AU565 cells. , 2013, Journal of agricultural and food chemistry.

[4]  Ananda Sen,et al.  Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. , 2010, Cancer research.

[5]  Yitao Wang,et al.  Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. , 2012, International journal of pharmaceutics.

[6]  M. Gottesman.  Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.

[7]  I. Gülçin.  Antioxidant properties of resveratrol: A structure–activity insight , 2010 .

[8]  B. Aggarwal,et al.  Chemosensitization of tumors by resveratrol , 2011, Annals of the New York Academy of Sciences.

[9]  Eun Seong Lee,et al.  Physicochemical characteristics of pH-sensitive poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) mixed micelles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Chang Gun Kim,et al.  Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. , 2008, Cancer letters.

[11]  W. Hennink,et al.  Cytostatic effect of xanthone-loaded mPEG-b-p(HPMAm-Lac2) micelles towards doxorubicin sensitive and resistant cancer cells. , 2012, Colloids and surfaces. B, Biointerfaces.

[12]  F. Figueiró,et al.  Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth. , 2013, Journal of biomedical nanotechnology.

[13]  Huibi Xu,et al.  Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. , 2011, Biomaterials.

[14]  Jiasen Cheng,et al.  Abrogation of G2/M arrest sensitizes curcumin‐resistant hepatoma cells to apoptosis , 2008, FEBS letters.

[15]  Yitao Wang,et al.  Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells. , 2013, The American journal of Chinese medicine.

[16]  Lin‐Yue Lanry Yung,et al.  Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting. , 2009, Journal of biomedical materials research. Part A.

[17]  Ramesh Vidavalur,et al.  Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. , 2006, Experimental and clinical cardiology.

[18]  F. Veiga,et al.  New delivery systems to improve the bioavailability of resveratrol , 2011, Expert opinion on drug delivery.

[19]  A. Tulpule,et al.  Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. , 1986, The Journal of biological chemistry.

[20]  R. Cichewicz,et al.  Resveratrol oligomers: Structure, chemistry, and biological activity , 2002 .

[21]  A. Mukhopadhyay,et al.  Breast cancer stem cells: a novel therapeutic target. , 2013, Clinical breast cancer.

[22]  Sunita Yadav,et al.  Multi-functional nanocarriers to overcome tumor drug resistance. , 2008, Cancer treatment reviews.

[23]  Jijin Gu,et al.  Enhanced antitumor efficacy by methotrexate conjugated Pluronic mixed micelles against KBv multidrug resistant cancer. , 2013, International journal of pharmaceutics.

[24]  Yitao Wang,et al.  Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma. , 2013, Journal of ethnopharmacology.

[25]  S. Bonin,et al.  Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy , 2013, Clinical Cancer Research.

[26]  C. Hwang,et al.  Ling-Zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells. , 2010, Journal of agricultural and food chemistry.

[27]  J. Shao,et al.  Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. , 2009, Colloids and surfaces. B, Biointerfaces.

[28]  Zhiping Zhang,et al.  The applications of Vitamin E TPGS in drug delivery. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  Hua Yang,et al.  Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. , 2003, Biomaterials.

[30]  Qiang Zhang,et al.  Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice. , 2011, Colloids and surfaces. B, Biointerfaces.

[31]  A. Elaissari,et al.  Nanotechnology olymer-based nanocapsules for drug delivery , 2009 .

[32]  R. Novak,et al.  DNA damage is an early event in doxorubicin-induced cardiac myocyte death. , 2006, American journal of physiology. Heart and circulatory physiology.

[33]  Si-Shen Feng,et al.  Vitamin E TPGS as a molecular biomaterial for drug delivery. , 2012, Biomaterials.

[34]  D. Scudiero,et al.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.

[35]  D. Kletsas,et al.  Resveratrol and related stilbenes: their anti-aging and anti-angiogenic properties. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  H. Chung,et al.  Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. , 2014, Biochimica et biophysica acta.

[37]  G. Sandri,et al.  Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications , 2012, International journal of nanomedicine.

[38]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[39]  T. He,et al.  A traditional Chinese medicine formulation consisting of Rhizoma Corydalis and Rhizoma Curcumae exerts synergistic anti-tumor activity. , 2009, Oncology reports.

[40]  S. Nazzal,et al.  Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[41]  L. Subramanian,et al.  Resveratrol: Challenges in Translation to the Clinic — A Critical Discussion , 2010, Clinical Cancer Research.

[42]  H. Su,et al.  N-Succinyl-chitosan nanoparticles induced mitochondria-dependent apoptosis in K562. , 2012, Molecular and cellular probes.

[43]  B. Aggarwal,et al.  Resveratrol: A multitargeted agent for age-associated chronic diseases , 2008, Cell cycle.